Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, has announced expanded capabilities for its lung disease software. The new features incorporate natural language processing (NLP) alongside imaging AI to extract clinical insights from electronic health records (EHRs)…
Kolmar BNH (KRX: 200130), the manufacturer of the immune-boosting health supplement HemoHim, has gained international recognition for its product quality from both the U.S. Food and Drug Administration (FDA) and Australia’s Therapeutic Goods Administration (TGA), further boosting its credibility in…
Waltz Health, a digital health company developing smarter, technology-enabled ways to price, distribute and prescribe medications and Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced a unique collaboration that…
VSee Health, Inc. (Nasdaq: VSEE), a leading provider of telehealth services that optimize workflow and enhance patient care, has launched a new program to address obesity and related health risks by integrating GLP-1 prescription medications into its existing telehealth platform.…
Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the closing of an oversubscribed $225 million Series B financing round. The syndicate wasled by General…
eClinicalWorks’ AI Technology Enables York Primary Care to Save Over an Hour Daily on Fax Management eClinicalWorks®, the largest ambulatory cloud EHR provider, has announced that York Primary Care is effectively utilizing its AI-powered EHR technology, including the innovative Image…
Survey Reveals 78% of Patients Experience Anxiety During Blood Draws; 74% Want Painless Home Collection Solutions Tasso, Inc., a leading provider of patient-centric blood collection solutions, surveyed over 600 adults in the U.S. to explore their experiences and preferences regarding…
Verastem Oncology Reports Promising RAMP 201 Data for Avutometinib and Defactinib in Low-Grade Serous Ovarian Cancer Verastem Oncology has announced encouraging results from its Phase 2 RAMP 201 trial, showcasing the combination of avutometinib and defactinib in patients with recurrent…
Lapetus Solutions Advocates for Shift from Disease Focus to Aging and Healthy Life Extension A recent paper published in Nature Aging, titled “Implausibility of Radical Life Extension in Humans in the 21st Century,” suggests that humanity may be nearing a…
The Mary Kay Ash Foundation® has announced $2.4 million in grants to support cancer research and domestic violence shelters across the U.S. Since its founding in 1996, the foundation has contributed over $96 million toward eliminating women-related cancers and ending…
Qatar-WHO Report: Lessons and Recommendations for Healthier Sporting Events Building on the experiences from the FIFA World Cup Qatar 2022, the State of Qatar and the World Health Organization (WHO) have released a new report that offers insights and recommendations…
Escalating Attacks on Healthcare Threaten Health Services in Lebanon Amid Conflict Since hostilities between Israel and Lebanon intensified on September 17, 2024, WHO has confirmed 23 attacks on healthcare in Lebanon, resulting in 72 deaths and 43 injuries among health…
